Level B· Emerging clinical evidence with positive signalsRandomized Controlled TrialEurope PMCOpen access

Cartilage repair: past and future--lessons for regenerative medicine

van Osch GJ., Brittberg M., Dennis JE., Bastiaansen-Jenniskens YM., Erben RG., Konttinen YT.

Randomized Controlled Trial on Cartilage Damage, published in J Cell Mol Med (2009) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Randomized Controlled Trial
Journal
J Cell Mol Med (2009)
Reported sample size
—
Source database
Europe PMC
PMID
19453519
PMCID
PMC3823400
DOI
10.1111/j.1582-4934.2009.00789.x
Citations
101

Abstract (original English)

Since the first cell therapeutic study to repair articular cartilage defects in the knee in 1994, several clinical studies have been reported. An overview of the results of clinical studies did not conclusively show improvement over conventional methods, mainly because few studies reach level I of evidence for effects on middle or long term. However, these explorative trials have provided valuable information about study design, mechanisms of repair and clinical outcome and have revealed that much is still unknown and further improvements are required. Furthermore, cellular and molecular studies using new technologies such as cell tracking, gene arrays and proteomics have provided more insight in the cell biology and mechanisms of joint surface regeneration. Besides articular cartilage, cartilage of other anatomical locations as well as progenitor cells are now considered as alternative cell sources. Growth Factor research has revealed some information on optimal conditions to support cartilage repair. Thus, there is hope for improvement. In order to obtain more robust and reproducible results, more detailed information is needed on many aspects including the fate of the cells, choice of cell type and culture parameters. As for the clinical aspects, it becomes clear that careful selection of patient groups is an important input parameter that should be optimized for each applic

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
Cartilage, ArticularChondrocytesAnimalsHumansJoint DiseasesOrthopedic ProceduresCell TransplantationMesenchymal Stem Cell TransplantationTransplantation, HomologousTissue Engineering

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research